Literature DB >> 23229707

Epidermal growth factor receptor inhibitors for treatment of orbital squamous cell carcinoma.

Tarek El-Sawy, Anita L Sabichi, Jeffrey N Myers, Merrill S Kies, William N William, Bonnie S Glisson, Scott Lippman, Bita Esmaeli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23229707     DOI: 10.1001/archophthalmol.2012.2515

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  7 in total

1.  [Conjunctival malignancies].

Authors:  Claudia Auw-Hädrich; Thomas Reinhard
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

2.  Perineural Spread of Cutaneous Squamous Cell Carcinoma Manifesting as Ophthalmoplegia.

Authors:  Antigoni Koukkoulli; Nikolas Koutroumanos; Desmond Kidd
Journal:  Neuroophthalmology       Date:  2015-06-17

Review 3.  Targeting EGFR and sonic hedgehog pathways for locally advanced eyelid and periocular carcinomas.

Authors:  Vivian T Yin; Helen Merritt; Bita Esmaeli
Journal:  World J Clin Cases       Date:  2014-09-16       Impact factor: 1.337

4.  Sellar, suprasellar, and parasellar masses: Imaging features and neurosurgical approaches.

Authors:  Bryan Lubomirsky; Zachary B Jenner; Morgan B Jude; Kiarash Shahlaie; Reza Assadsangabi; Vladimir Ivanovic
Journal:  Neuroradiol J       Date:  2021-12-02

Review 5.  Targeted therapy for orbital and periocular basal cell carcinoma and squamous cell carcinoma.

Authors:  Vivian T Yin; Margaret L Pfeiffer; Bita Esmaeli
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2013 Mar-Apr       Impact factor: 1.746

Review 6.  Ocular surface squamous neoplasia: management and outcomes.

Authors:  Roland Hӧllhumer; Susan Williams; Pamela Michelow
Journal:  Eye (Lond)       Date:  2021-02-09       Impact factor: 4.456

7.  Orbital Exenteration: A 23-year Report.

Authors:  Abolfazl Kasaee; Bahram Eshraghi; Shahbaz Nekoozadeh; Kambiz Ameli; Motahareh Sadeghi; Mansooreh Jamshidian-Tehrani
Journal:  Korean J Ophthalmol       Date:  2019-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.